Literature DB >> 16389357

Drug interactions due to cytochrome P450.

C C Ogu1, J L Maxa.   

Abstract

Cytochrome P450 is a family of isozymes responsible for the biotransformation of several drugs. Drug metabolism via the cytochrome P450 system has emerged as an important determinant in the occurrence of several drug interactions that can result in drug toxicities, reduced pharmacological effect, and adverse drug reactions. Recognizing whether the drugs involved act as enzyme substrates, inducers, or inhibitors can prevent clinically significant interactions from occurring. Avoiding coadministration or anticipating potential problems and adjusting a patient's drug regimen early in the course of therapy can provide optimal response with minimal adverse effects.

Entities:  

Year:  2000        PMID: 16389357      PMCID: PMC1312247          DOI: 10.1080/08998280.2000.11927719

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  5 in total

1.  Drug interactions.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  1999-07-02       Impact factor: 1.909

2.  Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

Authors:  P J Neuvonen; T Kantola; K T Kivistö
Journal:  Clin Pharmacol Ther       Date:  1998-03       Impact factor: 6.875

Review 3.  Cytochrome P450: new nomenclature and clinical implications.

Authors:  M J Cupp; T S Tracy
Journal:  Am Fam Physician       Date:  1998-01-01       Impact factor: 3.292

4.  Cytochrome P450: genetic polymorphism and drug interactions.

Authors:  F M Belpaire; M G Bogaert
Journal:  Acta Clin Belg       Date:  1996       Impact factor: 1.264

5.  Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.

Authors:  K T Kivistö; T Kantola; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

  5 in total
  71 in total

1.  Teriflunomide in relapsing multiple sclerosis: therapeutic utility.

Authors:  Mark S Freedman
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

2.  Medication use and multiple myeloma risk in Los Angeles County.

Authors:  Daniel S Nuyujukian; Jenna Voutsinas; Leslie Bernstein; Sophia S Wang
Journal:  Cancer Causes Control       Date:  2014-07-01       Impact factor: 2.506

3.  American Society of Nephrology quiz and questionnaire 2014: acid-base and electrolyte disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-23       Impact factor: 8.237

4.  Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction.

Authors:  Ryan S Funk; Jeffrey P Krise
Journal:  Mol Pharm       Date:  2012-04-06       Impact factor: 4.939

5.  Translational and transcriptional responses in human primary hepatocytes under hypoxia.

Authors:  Gaya K Hettiarachchi; Upendra K Katneni; Ryan C Hunt; Jacob M Kames; John C Athey; Haim Bar; Zuben E Sauna; Joseph R McGill; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-03-28       Impact factor: 4.052

Review 6.  Diagnostic molecular techniques in haematology: recent advances.

Authors:  Aikaterini Koutsi; Elisavet-Christina Vervesou
Journal:  Ann Transl Med       Date:  2018-06

7.  Specific packaging and circulation of cytochromes P450, especially 2E1 isozyme, in human plasma exosomes and their implications in cellular communications.

Authors:  Santosh Kumar; Namita Sinha; Kelli A Gerth; Mohammad A Rahman; Murali M Yallapu; Narasimha M Midde
Journal:  Biochem Biophys Res Commun       Date:  2017-07-26       Impact factor: 3.575

8.  Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system.

Authors:  Carlota Oleaga; Anne Riu; Sandra Rothemund; Andrea Lavado; Christopher W McAleer; Christopher J Long; Keisha Persaud; Narasimhan Sriram Narasimhan; My Tran; Jeffry Roles; Carlos A Carmona-Moran; Trevor Sasserath; Daniel H Elbrecht; Lee Kumanchik; L Richard Bridges; Candace Martin; Mark T Schnepper; Gail Ekman; Max Jackson; Ying I Wang; Reine Note; Jessica Langer; Silvia Teissier; James J Hickman
Journal:  Biomaterials       Date:  2018-08-04       Impact factor: 12.479

Review 9.  A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting.

Authors:  Komal P Singh; Anand A Dhruva; Elena Flowers; Kord M Kober; Christine Miaskowski
Journal:  Crit Rev Oncol Hematol       Date:  2017-11-20       Impact factor: 6.312

10.  The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects.

Authors:  Nisha Susan Thomas; Kiran George; Sivaranjani Arivalagan; Vijay Mani; Aktarul Islam Siddique; Nalini Namasivayam
Journal:  Eur J Nutr       Date:  2016-08-03       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.